Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy

被引:0
作者
Goudarzi, Mohammad Taghi Hedayati [1 ]
Moradi, Maryam [2 ]
Abrotan, Saeed [1 ]
Saravi, Mehrdad [2 ]
Shirafkan, Hoda [3 ]
Irilouzadian, Rana [4 ]
Omran, Hossein Salehi [1 ]
机构
[1] Babol Univ Med Sci, Rohani Hosp, Sch Med, Dept Cardiol, Babol, Iran
[2] Babol Univ Med Sci, Fac Med, Dept Cardiol, Babol, Iran
[3] Babol Univ Med Sci, Hlth Res Inst, Social Determinants Hlth Res Ctr, Babol, Iran
[4] Iran Univ Med Sci, Burn Res Ctr, Tehran, Iran
关键词
SUDDEN-DEATH; TASK-FORCE; THERAPY; POPULATION; PREVENTION; EFFICACY; OUTCOMES; SOCIETY;
D O I
10.1155/2023/4552100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having their own potential complications. Hypothesis. We aimed to investigate the prevalence of different complications of ICD insertion and the impact of the potential influential baseline characteristics in a one-year follow-up period. Methods. This was a retrospective study with a total of 71 HCM patients with ICD insertion. We evaluated the prevalence of different complications of ICD implantation and the impact of baseline characteristics on the occurrence of ICD complications using multivariate regression analysis in three 4-month periods. Results. In a one-year follow-up, 13 patients (18.3%) experienced at least one of the complications including pneumothorax, lead failure, ICD infection, inappropriate shocks, perforation, and upper limb deep vein thrombosis (DVT) with no mortality. Inappropriate shocks were reported as the most common (11.3%) complication during this period, with a gradual increase in the second (4.2%) and third (5.6%) follow-up sessions. Among all of the baseline characteristics that were investigated in this study, a positive history of hypertension was the only risk factor with significant impact on the occurrence of complications (P = 0.01). Conclusion. We demonstrated the occurrence of complications during a one-year follow-up as 18.3% in HCM patients with ICD insertion. A positive history of hypertension was the only baseline characteristic affecting the occurrence of complications, and inappropriate shocks were the most common complication.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
    Maron, Barry J.
    Spirito, Paolo
    Ackerman, Michael J.
    Casey, Susan A.
    Semsarian, Christopher
    Estes, N. A. Mark, III
    Shannon, Kevin M.
    Ashley, Euan A.
    Day, Sharlene M.
    Pacileo, Giuseppe
    Formisano, Francesco
    Devoto, Emmanuela
    Anastasakis, Aristidis
    Bos, J. Martijn
    Woo, Anna
    Autore, Camillo
    Pass, Robert H.
    Boriani, Giuseppe
    Garberich, Ross F.
    Almquist, Adrian K.
    Russell, Mark W.
    Boni, Luca
    Berger, Stuart
    Maron, Martin S.
    Link, Mark S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (14) : 1527 - 1535
  • [42] Appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: What happens on Sunday afternoons in May?
    Michels, Michelle
    EUROPACE, 2012, 14 (05): : 621 - 622
  • [43] Anxiety and depression as risk factors for ICD shocks and mortality in patients with an implantable cardioverter defibrillator - A systematic review
    Lindekilde, Nanna
    Skov, Ole
    Skovbakke, Soren J.
    Johansen, Jens B.
    Nielsen, Jens C.
    Pedersen, Susanne S.
    GENERAL HOSPITAL PSYCHIATRY, 2022, 78 : 96 - 107
  • [44] Use of β-Blockers in Patients with an Implantable Cardioverter Defibrillator
    LaPointe, Nancy M. Allen
    Stafford, Judith A.
    Pappas, Paul A.
    Al-Khatib, Sana M.
    Anstrorn, Kevin J.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1189 - 1196
  • [45] Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators
    Maron, Barry J.
    Casey, Susan A.
    Olivotto, Iacopo
    Sherrid, Mark V.
    Semsarian, Christopher
    Autore, Camillo
    Ahmed, Aisha
    Boriani, Giuseppe
    Francia, Pietro
    Winters, Stephen L.
    Giudici, Michael
    Koulova, Anna
    Garberich, Ross
    Rowin, Ethan J.
    Sears, Samuel F.
    Maron, Martin S.
    Spirito, Paolo
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (04)
  • [46] Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation
    Haines, David E.
    Wang, Yongfei
    Curtis, Jeptha
    CIRCULATION, 2011, 123 (19) : 2069 - 2076
  • [47] QRS Prolongation is Associated With High Defibrillation Thresholds During Cardioverter-Defibrillator Implantations in Patients With Hypertrophic Cardiomyopathy
    Nagai, Takayuki
    Kurita, Takashi
    Satomi, Kazuhiro
    Noda, Takashi
    Okamura, Hideo
    Shimizu, Wataru
    Suyama, Kazuhiro
    Aihara, Naohiko
    Kobayashi, Junjiro
    Kamakura, Shiro
    CIRCULATION JOURNAL, 2009, 73 (06) : 1028 - 1032
  • [48] Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator
    Takahashi, Atsushi
    Shiga, Tsuyoshi
    Shoda, Morio
    Tanizaki, Kohei
    Manaka, Tetsuyuki
    Ejima, Koichiro
    Kasanuki, Hiroshi
    Hagiwara, Nobuhisa
    HEART AND VESSELS, 2010, 25 (02) : 150 - 154
  • [49] Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy
    Wozniak, Olgierd
    Borowiec, Karolina
    Konka, Marek
    Cicha-Mikolajczyk, Alicja
    Przybylski, Andrzej
    Szumowski, Lukasz
    Hoffman, Piotr
    Poslednik, Krzysztof
    Biernacka, Elzbieta Katarzyna
    HEART, 2022, 108 (01) : 22 - +
  • [50] Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
    Francia, Pietro
    Ziacchi, Matteo
    Adduci, Carmen
    Ammendola, Ernesto
    Pieragnoli, Paolo
    De Filippo, Paolo
    Rapacciuolo, Antonio
    Rella, Valeria
    Migliore, Federico
    Viani, Stefano
    Musumeci, Maria Beatrice
    Biagini, Elena
    Lovecchio, Mariolina
    Baldini, Rossella
    Falasconi, Giulio
    Autore, Camillo
    Biffi, Mauro
    Cecchi, Franco
    EUROPACE, 2023, 25 (09):